Are We Doing Better a Decade Later?: Glaucoma in Patients with Boston Keratoprosthesis Type 1.
文献摘要
Purpose To compare glaucoma outcomes after Boston type 1 keratoprosthesis (KPro) implantation in a recent cohort with a previous cohort from a decade before. Design Retrospective comparative cohort study. Subjects Patients who underwent KPro surgery at Mass Eye and Ear: 67 eyes (64 patients) from 2016 to 2023 and 97 eyes (79 patients) from 2004 to 2009. Methods Development of de novo glaucoma and glaucoma progression were defined as an increase in cup-to-disc ratio (CDR) ≥0.2 from baseline to final follow-up, assessed by experienced KPro specialists and corroborated with OCT and Humphrey visual field (HVF) data when available. Main outcome measures Primary outcome was glaucoma progression within 4 years after KPro. Secondary outcomes were postoperative visual acuity (VA), intraocular pressure (IOP), and complications. Results Mean follow-up was similar between the recent and previous cohorts (3.2 ± 1.2 vs. 3.4 ± 1.1 years, P = 0.43). Prior infection and failed corneal grafts were more common in the recent cohort (43% vs. 22%, P = 0.003; 67% vs. 33%, P Conclusions Despite a greater baseline glaucoma burden, the recent cohort experienced lower rates of glaucoma progression and improved IOP control, likely reflecting earlier and more frequent surgical glaucoma interventions. Nonetheless, vision-threatening complications remain an ongoing challenge, emphasizing the need for continued effort to improve postoperative care for patients with keratoprosthesis. Financial disclosure(s) Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.